Enzymatica Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
18
- Stock Symbol
-
ENZY
- Investments
-
1
- Share Price
-
$0.24
- (As of Monday Closing)
Enzymatica General Information
Description
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme oral spray designed to treat and relieve cold and flu-like symptoms by creating a protective barrier against viruses in the upper respiratory tract. The company combines in-house enzyme production in Iceland with international distribution partnerships to drive expansion. Enzymatica currently sells products in Sweden, the UK and Iceland.
Contact Information
Website
www.enzymatica.comCorporate Office
- Ideon Science Park
- Scheelevägen 19
- 223 70 Lund
- Sweden
Corporate Office
- Ideon Science Park
- Scheelevägen 19
- 223 70 Lund
- Sweden
Enzymatica Stock Performance
As of 16-Nov-2026, Enzymatica’s stock price is $0.24. Its current market cap is $59M with 243M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.24 | $0.25 | $0.16 - $0.36 | $59M | 243M | 110K | -$0.02 |
Enzymatica Financials Summary
As of 30-Sep-2026, Enzymatica has a trailing 12-month revenue of $5.48M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 41,626 | 46,748 | 26,152 | 66,102 |
| Revenue | 5,479 | 5,486 | 4,309 | 4,789 |
| EBITDA | (4,292) | (4,784) | (4,380) | (3,901) |
| Net Income | (4,412) | (5,282) | (5,028) | (4,678) |
| Total Assets | 12,349 | 15,429 | 17,694 | 12,599 |
| Total Debt | 1,381 | 111 | 199 | 1,809 |
Enzymatica Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Enzymatica Patents
Enzymatica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3749296-A1 | Esters of hydroxy-benzoic acids for use in the treatment of rhinovirus | Active | 07-Feb-2018 | ||
| EP-3749296-B1 | Esters of hydroxy-benzoic acids for use in the treatment of rhinovirus | Inactive | 07-Feb-2018 | ||
| US-20210213112-A1 | Esters of hydroxy-benzoic acids for use in the treatment of rhinovirus | Inactive | 07-Feb-2018 | ||
| WO-2019154937-A1 | Esters of hydroxy-benzoic acids for use in the treatment of rhinovirus | Inactive | 07-Feb-2018 | ||
| ES-2900661-T3 | Hydroxy-benzoic acid esters for use in the treatment of rhinoviruses | Active | 07-Feb-2018 | A61K31/216 |
Enzymatica Signals
Enzymatica Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Enzymatica Acquisitions (1)
Enzymatica’s most recent deal was a Merger/Acquisition with Zymetech for . The deal was made on 01-Apr-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zymetech | 01-Apr-2016 | Merger/Acquisition | Pharmaceuticals |
Enzymatica ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Enzymatica Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Enzymatica Care | Lund, Sweden | 2006 |
Enzymatica FAQs
-
When was Enzymatica founded?
Enzymatica was founded in 2007.
-
Where is Enzymatica headquartered?
Enzymatica is headquartered in Lund, Sweden.
-
What is the size of Enzymatica?
Enzymatica has 18 total employees.
-
What industry is Enzymatica in?
Enzymatica’s primary industry is Other Devices and Supplies.
-
Is Enzymatica a private or public company?
Enzymatica is a Public company.
-
What is Enzymatica’s stock symbol?
The ticker symbol for Enzymatica is ENZY.
-
What is the current stock price of Enzymatica?
As of 16-Nov-2026 the stock price of Enzymatica is $0.24.
-
What is the current market cap of Enzymatica?
The current market capitalization of Enzymatica is $59M.
-
What is Enzymatica’s current revenue?
The trailing twelve month revenue for Enzymatica is $5.48M.
-
What is Enzymatica’s annual earnings per share (EPS)?
Enzymatica’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process